Robotic treatment of ureteropelvic junction obstruction in Eagle-Barrett Syndrome.

Eagle-Barrett Syndrome (EBS) is a rare congenital condition characterized by the triad of absent or defective abdominal wall muscles, urinary tract abnormalities, and bilateral cryptorchidism. Ureteropelvic junction obstruction (UPJO) is seldom reported in these patients, despite it being a common cause of childhood obstructive uropathy. We present the case of a patient with EBS who was subsequently identified as having symptomatic UPJO that was successfully treated with robotic pyeloplasty.

Initial Presentation and Outcomes of Testicular Cancer among Different Racial and Ethnic Groups at a Tertiary Care Facility in New Mexico.

INTRODUCTION: This study explored differences in testicular cancer presentation, treatment, compliance and outcomes among ethnicities in New Mexico. METHODS: A retrospective review of patients with testicular cancer treated between 2002 and 2015 was performed. Data included demographics, stage, delays in care, treatments, insurance status and nonadherence rates. RESULTS: Of 186 patients Hispanics and Native Americans presented at higher stage (p <0.01) and delayed treatment (p=0.02). Retroperitoneal lymph node dissection for stage I disease was 28% while stage II was 30%, compared to 18% and 58% nationally, respectively. Of stage II in Hispanic patients 24.5% received retroperitoneal lymph node dissection compared to 41.3% of Caucasians (p <0.05). Regarding chemotherapy Caucasian patients at stage I were more likely than Hispanics to receive chemotherapy (p <0.05). Hispanics had higher rates of nonadherence (p <0.01). Insurance rates did not differ among groups. However, insurance increased the likelihood for receiving chemotherapy/retroperitoneal lymph node dissection only for Caucasians. Lack of insurance increased active surveillance rates for stage I in Hispanics. The incidence of testicular cancer in Hispanics rose by 58% after 2009 (p <0.05). CONCLUSIONS: Minority groups presented at higher stages and delayed treatment. Retroperitoneal lymph node dissection rates differed nationally compared to this cohort with Hispanic patients at higher stage being less likely to receive retroperitoneal lymph node dissection. Meanwhile, Hispanics with stage I are less likely to obtain chemotherapy. Insurance rates did not differ among ethnicities but having insurance did not increase rates of chemotherapy/retroperitoneal lymph node dissection for Hispanics unlike for Caucasians. Meanwhile, lack of insurance increased stage I rates of active surveillance suggesting cultural/financial factors contribute to treatment decisions. Increased health literacy, outreach and access may aid in alleviating these disparities.

Adherence to AUA Clinical Guidelines: Motivations and Barriers.

INTRODUCTION: The AUA (American Urological Association) has been producing clinical practice guidelines to inform its members on standards of care since 1994. While adherence to these clinical practice guidelines varies, there are limited data on ways to improve adherence or reduce barriers to use. METHODS: A survey was developed to query adherence to AUA clinical practice guidelines and identify barriers to use. Five specific clinical practice guidelines were queried from various areas of urological care. Reasons for lack of adherence or perceived barriers to clinical practice guideline implementation were elicited. The survey was sent to a random sample of AUA members in clinical practice in the United States. RESULTS: Of the 2,455 AUA members surveyed 260 (10.6%) responded, with 148 (6.0%) answering all questions concerning AUA guidelines. Overall adherence to AUA guidelines was 72.7%. The guideline with the most adherence was for microhematuria (90.68%) and the least followed guideline was on the timing of post-vasectomy semen analysis (53.33%). The mean self-reported rate of adherence to the 5 guidelines was 81.7% (range 71.3% to 95.03%). The top reason given for lack of adherence was not agreeing with the guideline. The most commonly reported barriers to following clinical practice guidelines included insurance coverage (29.08%) and disagreement with guidelines (21.92%). CONCLUSIONS: Overall there is an optimistic view of the quality and applicability of clinical practice guidelines. These survey data help identify areas for improvement. We recommend e-mail distribution of clinical practice guidelines, improvement in ease of use for the mobile app, incorporation of clinical practice guidelines into the electronic medical record, and addition of CliffsNotes® and flowchart format to future clinical practice guidelines.

Tips and Tricks for Performing a Retrograde Pyelogram.

OBJECTIVE: To demonstrate indications, review tools and techniques, as well as abnormal findings when performing a retrograde pyelogram. METHODS: Retrograde pyelogram is a procedure which consists of introducing water-soluble contrast in a retrograde fashion into the ureter and collecting system of the kidney under fluoroscopic guidance. Conditions in which a retrograde pyelogram are indicated include iatrogenic ureteral injuries, ureteral obstruction, identification of stones or tumors, assistance for stent placement or ureteroscopy, and trauma evaluation. This video will explain surgical technique to perform a retrograde pyelogram in an operative setting. Normal and commonly encountered abnormal findings when performing a retrograde pyelogram will be reviewed. RESULTS: This video will review a series of 8 cases and will demonstrate normal and abnormal findings and complications identified when performing a retrograde pyelogram. In some cases, anterograde nephrostogram was also performed to further delineate the ureteral injury or obstructions. CONCLUSION: The tips and tricks reviewed can facilitate surgical techniques to perform a successful retrograde pyelogram and identify abnormal findings; especially in situations in which a urologist is not readily available. A retrograde pyelogram can be performed intraoperatively to identify iatrogenic ureteral injuries, ureteral obstruction, identification of stones or tumors, assistance of stent placement and ureteroscopy, and evaluation of trauma.

Evaluation of Missed Clinic Visits at an Academic Multi-Provider Urology Clinic.

INTRODUCTION: In this study we elucidated patient characteristics and reasons for visit associated with missed appointments for patients in a multi-provider urology clinic. METHODS: We retrospectively reviewed characteristics of clinic patient data for 4 urologists at 0.5 FTE (full-time equivalent) at a single location between March 18, 2014 and March 18, 2015. Data were collected on new and established patients, including age, health insurance status, time of appointment, reason for clinic visit and gender. The reasons for clinic visit were divided into 27 groups. We used chi-square analysis to evaluate statistical significance (p <0.05) based on expected rates for age, gender, time of appointment, season of appointment, health insurance status, benign vs malignant conditions and new or returning visit. RESULTS: A total of 4,812 clinic visits were analyzed with 999 missed patient appointments for an overall no-show rate of 20.76%. There was no statistically significant difference in the rate of attendance based on patient gender, season of appointment, or morning or afternoon appointment. A statistically significant difference was found in no-show rate between benign and malignant conditions (23.23% vs 8.85%, p <0.01) and whether it was a new or returning patient visit (29.78% vs 16.66%, p <0.01). In addition, there was a statistically significant difference in patients based on insurance status (p <0.01). Patients without insurance had the highest no-show rate and those with private insurance had the lowest (38.53% vs 16.35%). CONCLUSIONS: These data reveal identifiable characteristics associated with missed clinic visits.

Use of preoperative embolization prior to Transplant nephrectomy.

INTRODUCTION: After a failed transplant, management of a non-functional graft with pain or recurrent infections can be challenging. Transplant nephrectomy (TN) can be a morbid procedure with the potential for significant blood loss. Embolization of the renal artery alone has been proposed as a method of reducing complications from an in vivo failed kidney transplant. While this does yield less morbidity, it may not address an infected graft or refractory hematuria or rejection. We elected to begin preoperative embolization to assess if this would help decrease the blood loss and transfusion rate associated with TN. MATERIALS AND METHODS: We performed a retrospective analysis of all patients who underwent non-emergent TN at our institution. Patients who had functioning grafts that later failed were included in analysis. TN was performed for recurrent infections, pain or hematuria. We evaluated for blood loss (EBL) during TN, transfusion rate and length of hospital stay. RESULTS: A total of 16 patients were identified. Nine had preoperative embolization or no blood flow to the graft prior to TN. The remaining 7 did not have preoperative embolization. The shortest time from transplant to TN was 8 months and the longest 18 years with an average of 6.3 years. Average EBL for the embolized patients (ETN) was 143.9cc compared to 621.4cc in the non-embolized (NETN) group (p=0.041). Average number of units of blood transfused was 0.44 in the ETN with only 3/9 patients requiring transfusion. The NETN patients had average of 1.29 units transfused with 5/7 requiring transfusion. The length of stay was longer for the ETN (5.4 days) compared to 3.9 in the NETN. No intraoperative complications were seen in either group and only one patient had a postoperative ileus in the NETN. CONCLUSION: Embolization prior to TN significantly decreases the EBL but does not significantly decrease transfusion rate. However, patients do require a significantly longer hospitalization with embolization due to the time needed for embolization. Larger studies are needed to determine if embolization before transplant nephrectomy reduces the transfusion rates and overall complications.

Use of preoperative embolization prior to transplant nephrectomy

ABSTRACT Introduction After a failed transplant, management of a non-functional graft with pain or recurrent infections can be challenging. Transplant nephrectomy (TN) can be a morbid procedure with the potential for significant blood loss. Embolization of the renal artery alone has been proposed as a method of reducing complications from an in vivo failed kidney transplant. While this does yield less morbidity, it may not address an infected graft or refractory hematuria or rejection. We elected to begin preoperative embolization to assess if this would help decrease the blood loss and transfusion rate associated with TN. Materials and Methods We performed a retrospective analysis of all patients who underwent non-emergent TN at our institution. Patients who had functioning grafts that later failed were included in analysis. TN was performed for recurrent infections, pain or hematuria. We evaluated for blood loss (EBL) during TN, transfusion rate and length of hospital stay. Results A total of 16 patients were identified. Nine had preoperative embolization or no blood flow to the graft prior to TN. The remaining 7 did not have preoperative embolization. The shortest time from transplant to TN was 8 months and the longest 18 years with an average of 6.3 years. Average EBL for the embolized patients (ETN) was 143.9cc compared to 621.4cc in the non-embolized (NETN) group (p=0.041). Average number of units of blood transfused was 0.44 in the ETN with only 3/9 patients requiring transfusion. The NETN patients had average of 1.29 units transfused with 5/7 requiring transfusion. The length of stay was longer for the ETN (5.4 days) compared to 3.9 in the NETN. No intraoperative complications were seen in either group and only one patient had a postoperative ileus in the NETN. Conclusion Embolization prior to TN significantly decreases the EBL but does not significantly decrease transfusion rate. However, patients do require a significantly longer hospitalization with embolization due to the time needed for embolization. Larger studies are needed to determine if embolization before transplant nephrectomy reduces the transfusion rates and overall complications.

Contemporary Series of Robotic-Assisted Distal Ureteral Reconstruction Utilizing Side Docking Position

Purpose: The robot-assisted approach to distal ureteral reconstruction is increasingly utilized. Traditionally, the robot is docked between the legs in lithotomy position resulting in limited bladder access for stent placement. We examined the use of side docking of the daVinci robot® to perform distal ureteral reconstruction. Materials and Methods: A retrospective review of distal ureteral reconstruction (ureteral reimplantation and uretero-ureterostomy) executed robotically was performed at a single institution by a single surgeon. The daVinci robotic® Si surgical platform was positioned at the right side of the patient facing towards the head of the patient, i.e. side docking. Results: A total of 14 cases were identified from 2011–2013. Nine patients underwent ureteral reimplantation for ureteral injury, two for vesicoureteral reflux, one for ureteral stricture, and one for megaureter. One patient had an uretero-ureterostomy for a distal stricture. Three patients required a Boari flap due to extensive ureteral injury. Mean operative time was 286 minutes (189–364), mean estimated blood loss was 40cc (10–200), and mean length of stay was 2.3 days (1–4). Follow-up renal ultrasound was available for review in 10/14 patients and revealed no long-term complications in any patient. Mean follow-up was 20.7 months (0.1–59.3). Conclusion: Robot-assisted laparoscopic distal ureteral reconstruction is safe and effective. Side docking of the robot allows ready access to the perineum and acceptable placement of the robot to successfully complete ureteral repair.

Contemporary Series of Robotic-Assisted Distal Ureteral Reconstruction Utilizing Side Docking Position.

PURPOSE: The robot-assisted approach to distal ureteral reconstruction is increasingly utilized. Traditionally, the robot is docked between the legs in lithotomy position resulting in limited bladder access for stent placement. We examined the use of side docking of the daVinci robot® to perform distal ureteral reconstruction. MATERIALS AND METHODS: A retrospective review of distal ureteral reconstruction (ureteral reimplantation and uretero-ureterostomy) executed robotically was performed at a single institution by a single surgeon. The daVinci robotic® Si surgical platform was positioned at the right side of the patient facing towards the head of the patient, i.e. side docking. RESULTS: A total of 14 cases were identified from 2011-2013. Nine patients underwent ureteral reimplantation for ureteral injury, two for vesicoureteral reflux, one for ureteral stricture, and one for megaureter. One patient had an uretero-ureterostomy for a distal stricture. Three patients required a Boari flap due to extensive ureteral injury. Mean operative time was 286 minutes (189-364), mean estimated blood loss was 40cc (10-200), and mean length of stay was 2.3 days (1-4). Follow-up renal ultrasound was available for review in 10/14 patients and revealed no long-term complications in any patient. Mean follow-up was 20.7 months (0.1-59.3). CONCLUSION: Robot-assisted laparoscopic distal ureteral reconstruction is safe and effective. Side docking of the robot allows ready access to the perineum and acceptable placement of the robot to successfully complete ureteral repair.

Nephrolithiasis and pregnancy: has the incidence been rising?

INTRODUCTION: The incidence of nephrolithiasis has consistently been increasing over recent decades. This has been attributed to diet, obesity, environmental temperature changes, and comorbid diseases such as diabetes. Incidence change has not been studied in the pregnant population. Herein, we report our experience with stone diagnosis in this unique patient population over the past 2 decades. METHODS: Hospital data from a tertiary women's hospital were examined for international classification of diseases, ninth revision (ICD-9) codes for pregnancy (640-648, V22.0, V22.1, V22.2), and urolithiasis (592.0, 592.1, 592.9) between 1991 and 2011. The change in incidence in nephrolithiasis, pregnancy, and the combination of both was examined. RESULTS: In the 21-year period studied, 876 pregnant patients were given a diagnosis of nephrolithiasis at our hospital. Over the same time, 204,034 pregnant patients and 3262 patients with stones were treated. Comparing patients seen from 1991-2000 to those seen from 2001-2011 revealed a significant increase in patients with stones (78 vs. 226/year, p=0.004), but no change in pregnant patients (9467 vs. 9942/year, p=0.3) or pregnant patients with stones (36 vs. 47, p=0.1). Evaluating patients at 5-year intervals confirmed the expected increase in patients with stones, but no change in incidence of nephrolithiasis in pregnant patients was noted. CONCLUSION: There was no change in incidence of nephrolithiasis in pregnant patients over a 2-decade period. Further research is warranted to determine why the pregnant population does not have the expected increase in nephrolithiasis. Larger, multi-institutional studies are needed to validate our results.

Effect of magnesium on calcium and oxalate ion binding.

BACKGROUND AND PURPOSE: Magnesium (Mg(2+)) has been shown to be a kidney stone inhibitor; however, the exact mechanism of its effect is unknown. Using theoretical models, the interactions of calcium and oxalate were examined in the presence of Mg(2+). METHODS: Molecular dynamics simulations were performed with NAMD and CHARMM27 force field. The interaction between calcium (Ca(2+)) and oxalate (Ox(2-)) ions was examined with and without magnesium. Concentrations of calcium and oxalate were 0.1 M and 0.03 M, respectively, and placed in a cubic box of length ~115 Angstrom. Na(+) and Cl(-) ions were inserted to meet system electroneutrality. Mg(2+) was then placed into the box at physiologic concentrations and the interaction between calcium and oxalate was observed. In addition, the effect of citrate and pH were examined in regard to the effect of Mg(2+) inhibition. Each system was allowed to run until a stable crystalline structure was formed. RESULTS: The presence of Mg(2+) reduces the average size of the calcium oxalate and calcium phosphate aggregates. This effect is found to be Mg(2+) concentration-dependent. It is also found that Mg(2+) inhibition is synergistic with citrate and continues to be effective at acidic pH levels. CONCLUSION: The presence of magnesium ions tends to destabilize calcium oxalate ion pairs and reduce the size of their aggregates. Mg(2+) inhibitory effect is synergistic with citrate and remains effective in acidic environments. Further studies are needed to see if this can be applied to in vivo models as well as extending this to other stone inhibitors and promoters.

Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance.

OBJECTIVE: To assess the efficacy of dietary management for the treatment of idiopathic hyperoxaluria in a large tertiary care center and examine the influence of patient factors, compliance, and follow-up on oxalate reduction, which has not been previously investigated. METHODS: Retrospectively, 149 patients with kidney stones with idiopathic hyperoxaluria who received dietary management at our stone clinic were evaluated. Changes in urinary parameters on 24-hour urine collections were calculated for all patients and those with abnormal values in the overall short-term (30-240 days) and long-term (>240 days) time periods. Changes in urinary oxalate were evaluated with respect to patient characteristics and compliance measures. RESULTS: Urine oxalate and supersaturation of calcium oxalate were significantly (P < .001) reduced by 8.9 ± 19.2 mg/d and 1.7 ± 4.3, respectively. A total of 48.3% of the patients reduced their urinary oxalate to normal. Urine oxalate reductions were similar in the short-term and long-term periods. Women lowered urine oxalate nearly twice as much as men (12.7 ± 2.0 mg/d vs 6.7 ± 2.2 mg/d, P = .022) and body mass index (BMI) negatively correlated with oxalate reduction (Pearson's r = -0.213). Reported noncompliance and keeping follow-up appointments did not affect oxalate, however, there was a significant correlation between increasing urine volume and reducing oxalate (Pearson's r = -0.21). CONCLUSION: This study confirms that meaningful reductions of urine oxalate and supersaturation of calcium oxalate can be achieved with dietary management of hyperoxaluria on a larger clinical scale. Furthermore, we identified that women and patients with low BMIs had greater urine oxalate reductions and urine volume may also be used by clinicians as a measure of dietary compliance.

Stone management for the patient on anticoagulation.

Use of chronic anticoagulation has increased recently, leading to more surgical intervention on patients taking chronic anticoagulation. This review discusses anticoagulation and the management of urolithiasis.

Retrograde ureteroscopy for renal stones larger than 2.5 cm.

INTRODUCTION AND OBJECTIVES: Because of the advances in endoscopic technology, retrograde flexible ureteroscopy (URS) is being applied to larger renal stone burdens. For stones greater than 2.5 cm, percutaneous nephrolithotomy has long been considered the standard of care. We have encountered a growing population of patients who desire a less invasive, less disruptive approach to large renal stones. We present our experience with retrograde ureteroscopic management of renal stones larger than 2.5 cm. METHODS: Twenty-two patients between October 2004 and June 2008 underwent retrograde flexible URS with holmium laser lithotripsy. Each patient underwent retrograde URS using the Storz Flex-X and a ureteral access sheath. Patients were evaluated for number of procedures, stone clearance rates, and hospital admissions. Postoperative kidney, ureter, and bladder radiograph was used to determine stone-free rates. RESULTS: Mean stone size was 3.0 cm. The average number of procedures was 1.82 with 5 patients requiring one, 14 requiring two, and 1 requiring three procedures. There were two failures who went on to have percutaneous nephrolithotomy, both of whom had significant lower pole stone burden. Overall stone-free rate was 90.9%. There were three overnight admissions for stent pain, and one 3-day admission for bacteremia in a patient who was noncompliant with preoperative antibiotics. CONCLUSIONS: Planned staged URS is a viable option for the treatment of renal stones larger than 2.5 cm with excellent stone-free results. Significant lower pole stone burden is a limiting factor.